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Title: The performance of preference-based instrumental variables to emulate a 
randomised clinical trial of comparative medical device effectiveness. 
 
A Prats-Uribe, K Berencsi, A Carr, A Judge, A Silman, DW Murray, NK Arden, DW Murray, I Petersen, D 
Beard, JM Wilkinson, I Douglas, JM Valderas, S Lamb, V Y Strauss, and D Prieto-Alhambra  
Background:  
Instrumental variables (IV) are used to minimize confounding in pharmacoepidemiology. There is a 
scarcity of data on the performance of preference-based IVs in medical device epidemiology. 
Objectives:  
We aimed to test the use of surgeon, centre and regional preferences for partial knee replacement 
(PKR) as IVs to replicate an ongoing RCT comparing PKR vs total knee replacement (TKR), the TOPKAT 
trial. 
Methods:   
Participants undergoing PKR or TKR according to the UK National Joint Registry, and with linked post-
operative patient reported oxford knee scores (OKS) data were included. TOPKAT exclusion criteria 
were applied to maximise comparability. 
We calculated preference as the % of PKR in the last 20, 30 and 50 knee replacement surgeries for 
lead and consultant surgeon, and the last 100, 300, 500, and 1000 for surgical unit and regional area. 
We estimated IV strength using F-statistic and odds ratio (OR) on a regression between IV and 
exposure (PKR). We evaluated balance per groups (IV>median vs IV൑median) with standardized mean 
differences (SMD) for known confounders. IVs with confounding (SMD >=0.1) and those considered 
weak (OR 95% confidence intervals including 1 or F-statistic<10) were not further evaluated. A 2-stage 
IV regression was fitted to calculate the effect of PKR on one-year OKS compared to TKR. We used ݔଶ 
to test differences in treatment estimates between TOPKAT and IVs results; and ߬ଶ to quantify 
between-studies variance. 
Results:  
A total of 69,269 patients were included for preference calculations; 34,576 had OKS data and were 
included, with 358 undergoing PKR.  Lead surgeon preference based on 30 and 50 surgeries did not 
balance for age; while consultant preference based on previous 50 surgeries, and all area (surgical unit 
and region-based) IVs resulted in imbalances in socio-economic status.  
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The results from lead surgeon preference IV based on 20 previous surgeries were comparable to 
TOPKAT: 9.1 (CI95: 0.1 to 18.1) vs 1.9 (0.2 to 3.6) respectively; ݔଶ  p=0.12; ߬ଶ=15. Conversely, 
consultant preference IV based on 20 and 30 previous surgeries yielded significantly different results, 
with ݔଶ p=0.01 and p<0.01 respectively. 
Conclusions:  
Surgeon preference is a potentially valid IV, but treatment estimates are sensitive to decisions made 
during the construction of IVs. More research is needed on best practices for the estimation and 
diagnostics of surgeon preference IVs. Finally, caution is advised in the interpretation of area-based 
IVs, which fail to balance regional confounders such as deprivation. 
 
